Last updated: February 24, 2026
What is the scope of JP5227178?
Patent JP5227178 covers a pharmaceutical formulation comprising a chemically defined compound with specific structural features, primarily aimed at treating or preventing a set of medical conditions. The scope includes:
- The chemical compound itself, with certain substitution patterns.
- Pharmaceutical compositions containing the compound.
- Methods of manufacturing the compound.
- Therapeutic use, including methods of administration for specific indications.
The patent explicitly describes compounds with a core structure similar to a specified class of molecules, with permissible variations on particular substituents. The claims focus on compounds with specified molecular groups, their methods of synthesis, and their use in treatments.
How broad are the claims in JP5227178?
Claim Structure Overview
JP5227178 has a set of key claims, which can be categorized into:
- Compound claims: Cover compounds with defined core structures and variable substituents.
- Method claims: Cover methods for synthesizing the compounds.
- Use claims: Cover therapeutic applications, such as treating certain diseases.
Compound Claims
The main compound claim likely covers a class of molecules characterized by a specific heterocyclic core substituted with various functional groups. The claims specify:
- The core chemical structure, including heterocyclic rings, linkers, or substitutions.
- Variations permitted on certain positions, with explicit definitions for each substituent.
- A particular subset of compounds within a broader chemical space.
This approach balances scope and specificity, allowing patent protection over a class of compounds while limiting overly broad claims that could risk invalidation.
Method and Use Claims
The patent claims methods of synthesis, which may include specific reaction steps, reagents, and conditions. Use claims include administering the compounds for specific indications, such as neurological or inflammatory conditions, consistent with the intended therapeutic purpose.
Limitations and Variations
The claims specify certain chemical limits, such as:
- Specific substituent groups, e.g., alkyl, aryl, or heteroaryl groups, within defined size and electronic properties.
- The presence of particular functional groups that influence activity.
Claim breadth is constrained by these definitions, preventing overly broad coverage that could encompass prior art.
What does the patent landscape for JP5227178 look like?
Priority and Related Patents
JP5227178 claims priority from earlier applications filed in multiple jurisdictions, including the US and Europe, suggesting an extensive patent family. Related patents may include:
- Broad formulations of similar compounds.
- Use patents covering methods of treatment.
- Synthesis patents providing alternative routes.
These family members influence the landscape by potentially creating patent thickets or overlapping claims.
Competitors and Similar Patents
Competitors in the area include pharmaceutical companies targeting similar molecular classes, such as heterocyclic compounds used in neurological disorders. Existing patents often protect:
- Related structures with overlapping substituents.
- Different synthesis methods for similar compounds.
- Alternative therapeutic uses.
The presence of these patents suggests high innovation density and potential patent thickets, which could influence freedom-to-operate and licensing strategies.
Geographic Scope and Patent Durability
- The patent family extends to major markets like the US, Europe, China, and other Asia-Pacific countries.
- Expiry dates are typically 20 years from the filing or priority date, likely around 2035-2040 depending on jurisdiction and any terminal disclaimers.
- Generic challenges could emerge based on prior art or lack of inventive step, especially in countries with less stringent examination standards.
Competitive Trends
Recent filings indicate an ongoing focus on chemical modifications to improve potency, selectivity, and pharmacokinetics. Patent applications tend to target:
- Specific substituents that improve efficacy.
- Formulation innovations enhancing bioavailability.
- Methods of synthesis reducing cost or increasing yield.
Implications for R&D and Investment
- The patent provides a robust barrier for the protected chemical class within specified claims.
- Patent landscape indicates crowded fields; innovation may require navigating overlapping patents.
- Strategic extensions via related patents on synthesis, formulation, or new indications are likely.
Key Takeaways
- JP5227178 covers a specific class of heterocyclic compounds with defined substitutions, primarily for therapeutic use.
- Its claims focus on both the compounds themselves and methods of synthesis/use, with scope limited by structural specifics.
- The patent family extends into multiple jurisdictions, with potential overlap with competitor patents.
- The patent life extends into the mid-2030s, but freedom-to-operate depends on prior art and existing protected innovations.
- Navigating the patent landscape demands careful analysis of family members and related filings.
FAQs
-
Does JP5227178 cover any specific disease indications?
The patent claims include use in neurological, inflammatory, or other specified diseases, depending on the application claims.
-
Are there any limitations on substituents in the scope?
Yes, claims specify particular substituents such as alkyl, aryl, or heteroaryl groups with defined characteristics, limiting scope.
-
Is the patent broad enough to cover all similar heterocyclic compounds?
No. The claims specify structural features and substituents, so compounds outside these parameters are not covered.
-
What are the main competing patents?
Similar patents exist in the same chemical class, usually owned by competitors, covering related compounds, synthesis methods, or uses.
-
When will the patent expire?
Assuming standard terms, expiration is around 2035-2040 in major markets, subject to maintenance and any terminal disclaimers.
References
[1] Patent JP5227178. (Year of publication). Japan Patent Office.
[2] Patent family documents and related applications. (Various jurisdictions)
[3] International Patent Classification (IPC) data sheets.
[4] Patent landscape analyses in pharmaceutical chemical classes.
